Ramakanth Sarabu | |
|---|---|
 Image of Ramakanth Sarabu | |
| Born | Ramakanth Sarabu June 20, 1955 |
| Died | February 11, 2021 (aged 65) |
| Nationality | Indian |
| Citizenship | American |
| Alma mater | Osmania University * Indian Institute of Technology * Case Western Reserve University * Harvard University |
| Scientific career | |
| Fields | Medicinal Chemistry Organic Chemistry Drug Discovery Diabetes Research |
| Institutions | Hoffmann-La Roche Biocon Bristol Myers Squib Cellarity |
Ramakanth Sarabu (June 20, 1955 – February 11, 2021) was an Indian organic chemist. He is known for his contributions in diabetes research, specifically the work of Glucokinase activation as a treatment therapy for type 2 diabetes.
Ramakanth Sarabu was born in Hyderabad, Telangana where he received his early education. He earned a master's degree from Osmania University in Organic Chemistry and his doctorate from Indian Institute of Technology, Madras in Molecular Rearrangements from 1979 to 1984.[1] In 1984 he moved to the US to pursue post-doctoral fellowship under Elias James Corey, at Harvard University.[2][3][4] He did a second post-doctoral fellowship in 1985 at Case Western University in Cleveland, OH.[5][6] He is known for his works and contributions in the domain of Glucokinase activation as a treatment therapy for type 2 diabetes.[7]
He died on 11 February 2021 in Montville, New Jersey,[8] while serving as the Head of Chemistry at Cellarity.[9][10] Prior to that, from 1997 to 2012, he served at Hoffmann-La Roche at different positions like Research Leader, Senior Principal Scientist etc.[11] He then went on to become the Head of Medicinal Chemistry at Biocon Bristol Myers Squibb R&D Center from 2012 to 2019.[12][13][14][15]
